Research Topics
Species | S EzzatSummaryAffiliation: Mount Sinai Hospital Country: Canada Publications
| Collaborators
|
Detail Information
Publications
A soluble dominant negative fibroblast growth factor receptor 4 isoform in human MCF-7 breast cancer cellsS Ezzat
Department of Medicine, University of Toronto, 600 University Avenue, Toronto, Ontario, Canada M5G 1X5
Biochem Biophys Res Commun 287:60-5. 2001..These findings represent the first description of an endogenous soluble C-terminally truncated FGFR4 isoform with FGF modulatory properties...
Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: a mechanism underlying pituitary neoplasiaShereen Ezzat
Department of Medicine, University of Toronto, Canada
Mol Endocrinol 18:2543-52. 2004....
The prevalence of pituitary adenomas: a systematic reviewShereen Ezzat
Department of Medicine, University of Toronto and Mount Sinai Hospital, Toronto, Ontario, Canada
Cancer 101:613-9. 2004..With these additional classifications in mind, the goals of the current study were to determine the prevalence of pituitary adenomas and to explore the clinical relevance of the findings...
Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer--a randomized controlled trialAnna M Sawka
Division of Endocrinology, Department of Medicine, University Health Network and University of Toronto, Toronto, Ontario, Canada
Trials 11:81. 2010..This decision is often difficult because of conflicting reports of RAI treatment benefit and medical evidence uncertainty due to the lack of long-term randomized controlled trials...
The molecular pathogenetic role of cell adhesion in endocrine neoplasiaS Ezzat
Department of Medicine, University of Toronto, Endocrine Oncology Site Group, Mount Sinai and Princess Margaret Hospitals, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada M5G 1X5
J Clin Pathol 58:1121-5. 2005..Validation of the functional relevance of these adhesive pathways will be discussed in light of targeted pharmacotherapeutic studies that are unmasking novel approaches to the treatment of neuroendocrine tumours...
A Canadian multi-centre, open-label long-term study of Pegvisomant treatment in refractory acromegalyShereen Ezzat
University of Toronto, Mount Sinai Hospital, Toronto, ON, M5G 1X5
Clin Invest Med 32:E265. 2009..Here we report the results of a Canadian multi-centre study open-label, dose-titrated long-term study examining safety and efficacy outcomes of a growth hormone receptor antagonist, pegvisomant in 19 patients with refractory acromegaly...
The role of hormones, growth factors and their receptors in pituitary tumorigenesisS Ezzat
Department of Medicine, University of Toronto, and The Freeman Centre for Endocrine Oncology, Mount Sinai Hospital, Ontario, Canada
Brain Pathol 11:356-70. 2001....
Canadian consensus guidelines for the diagnosis and management of acromegalyShereen Ezzat
University of Toronto, Toronto, Ontario
Clin Invest Med 29:29-39. 2006..This paper summarizes the working group's findings and the points of consensus that were achieved...
Pharmacological approach to the treatment of acromegalyShereen Ezzat
Division of Endocrinology and Metabolism, University of Toronto, Ontario, Canada
Neurosurg Focus 16:E3. 2004..This last line of therapy should be considered for use in patients in whom surgery and medical therapy with somatostatin and/or dopamine agonists are either ineffective or poorly tolerated...
FGF receptor signaling at the crossroads of endocrine homeostasis and tumorigenesisS Ezzat
Department of Medicine, University of Toronto, Endocrine Oncology Site Group, Mount Sinai and Princess Margaret Hospitals, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada
Horm Metab Res 37:355-60. 2005..This review will examine the evidence that FGF/FGFRs play a role in sporadic endocrine neoplasia and the pathways in which these molecules may be selectively targeted for therapeutic purposes...
Pharmacological options in the treatment of acromegalyShereen Ezzat
Mount Sinai Hospital, University of Toronto, Canada
Curr Opin Investig Drugs 6:1023-7. 2005..This review will summarize the current major classes of pharmacotherapeutic agents with special emphasis on their recognized benefits and risks...
Thyroid cancer patients' involvement in adjuvant radioactive iodine treatment decision-making and decision regret: an exploratory studyA M Sawka
Division of Endocrinology, Department of Medicine, University Health Network Toronto General Hospital, 200 Elizabeth Street, 12 EN 212, Toronto, Ontario, Canada M5G 2C4
Support Care Cancer 20:641-5. 2012..We explored regret in thyroid cancer patients, relating to the decision to accept or reject adjuvant radioactive iodine treatment...
Circulating IGF-I levels in monitoring and predicting efficacy during long-term GH treatment of GH-deficient adultsS Ezzat
Division of Endocrinology and Metabolism, University of Toronto, Canada
Eur J Endocrinol 149:499-509. 2003..Our findings validate the importance of sustained GH therapy, but caution on the interpretation of IGF-I levels in monitoring the long-term effects of GH treatment...
The MEN-1 gene is rarely down-regulated in pituitary adenomasS L Asa
Department of Pathology, Mount Sinai Hospital, University of Toronto, Ontario, Canada
J Clin Endocrinol Metab 83:3210-2. 1998....
The endogenous fibroblast growth factor-2 antisense gene product regulates pituitary cell growth and hormone productionS L Asa
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada M5G 2M9
Mol Endocrinol 15:589-99. 2001..GFG represents a novel mechanism involved in restraining pituitary tumor cell growth while promoting hormonal activity...
Evidence for growth hormone (GH) autoregulation in pituitary somatotrophs in GH antagonist-transgenic mice and GH receptor-deficient miceS L Asa
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
Am J Pathol 156:1009-15. 2000..This represents the first evidence of direct GH feedback inhibition on pituitary somatotrophs, which may have implications for the use of GH analogs in different clinical settings...
The insulin resistance Grb14 adaptor protein promotes thyroid cancer ret signaling and progressionK Balogh
Department of Medicine, University Health Network, Toronto, Ontario, Canada
Oncogene 31:4012-21. 2012..Our findings uncover a new role for Grb14 in finely tuning receptor signaling and modulating thyroid cancer progression...
Immunohistochemical diagnosis of papillary thyroid carcinomaC C Cheung
Department of Pathology Medicine, The Freeman Center in Endocrine Onology, Mount Sinai Hospital, University of Toronto, Toronto Canada
Mod Pathol 14:338-42. 2001..HBME-1 positivity indicates malignancy but not papillary differentiation. Only rarely are all three markers negative in PC; this panel therefore provides an objective and reproducible tool for the analysis of difficult thyroid nodules...
The spectrum and significance of primary hypophysitisC C Cheung
The Freeman Center for Endocrine Oncology, Mount Sinai Hospital, Department of Pathology, University of Toronto, Toronto, Ontario M5G 1X5, Canada
J Clin Endocrinol Metab 86:1048-53. 2001..Histological confirmation of the diagnosis of hypophysitis can be obtained by performing a biopsy or by requesting an intraoperative frozen section consultation...
Growth hormone-releasing hormone (GHRH) and GHRH receptor (GHRH-R) isoform expression in ectopic acromegalyN H Othman
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, 600 University Avenue, Toronto, Ontario, Canada
Clin Endocrinol (Oxf) 55:135-40. 2001....
The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegalyShelly Bhayana
Department of Medicine, Mount Sinai Hospital, 600 University Avenue, Room 437, Toronto, Ontario, Canada M5G 1X5
J Clin Endocrinol Metab 90:6290-5. 2005..77; 95% CI, 1.01-885.45; P < 0.05). CONCLUSIONS: Somatotroph tumor type represents a strong clinical predictor of response to SSA treatment and will help to identify patients who warrant more vigilant management of their disease...
Analysis of ret/PTC gene rearrangements refines the fine needle aspiration diagnosis of thyroid cancerC C Cheung
Department of Pathology and Laboratory Medicine, The Freeman Center for Endocrine Oncology, Mount Sinai Hospital, University of Toronto, Ontario, Canada M5G 2M9
J Clin Endocrinol Metab 86:2187-90. 2001..The results indicate that RT-PCR for ret/PTC is a specific marker that can be applied to fine needle aspiration biopsies and improves the diagnosis of malignancy when used as an adjunct to traditional cytology...
Distinct clonal composition of primary and metastatic adrencorticotrophic hormone-producing pituitary carcinomaA Zahedi
Department of Medicine, The University of Toronto, Toronto, Ontario, Canada
Clin Endocrinol (Oxf) 55:549-56. 2001..This is the first description of a metastatic pituitary carcinoma with a distinct clonal composition from its primary source...
CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastasesW Liu
Department of Pathology, University Health Network and Toronto Medical Laboratories, and University Hospital Hamburg Eppendorf, Ontario, Canada
Oncogene 26:2747-58. 2007..Our data highlight a complex repertoire of actions providing a putative mechanism underlying the spectrum of biologic behaviors associated with thyroid cancer...
AcromegalyS Ezzat
University of Toronto, Wellesley Hospital, Ontario, Canada
Endocrinol Metab Clin North Am 26:703-23. 1997..This article reviews recent advances in our understanding of acromegaly and the impact of current approaches on the diagnosis and monitoring of patients with this disorder...
The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adultsLinda J Woodhouse
School of Rehabilitation Science, McMaster University, Hamilton, Ontario, Canada
Endocr Rev 27:287-317. 2006....
AIP Mutations are not identified in patients with sporadic pituitary adenomasRebecca Digiovanni
Department of Pathology, University Health Network and Toronto Medical Laboratories, Ontario Cancer Institute, Toronto, Ontario, Canada
Endocr Pathol 18:76-8. 2007..Our results indicate that mutations in AIP are not identified in sporadic pituitary adenomas of Canadian patients. This rare mechanism of pituitary tumorigenesis appears to be unique to the initial Finnish and Italian families described...
Clinical predictors of advanced sellar massesGloria M Rambaldini
Department of Medicine, York Central Hospital, Richmond Hill, Ontario, Canada
Endocr Pract 13:609-14. 2007..To identify clinical variables associated with the presence of a structurally advanced sellar mass (ASM)...
Ventilation threshold as a measure of impaired physical performance in adults with growth hormone excessScott G Thomas
Departments of Physical Therapy and Medicine, The University of Toronto, Toronto, Ontario, Canada
Clin Endocrinol (Oxf) 56:351-8. 2002..Taken together, these data suggest that a narrow window for GH/IGF-I levels is required to maintain optimal physical function...
How can we meet the information needs of patients with early stage papillary thyroid cancer considering radioactive iodine remnant ablation?A M Sawka
Division of Endocrinology, Department of Medicine, University Health Network, University of Toronto, 200 Elizabeth Street, Toronto, Ontario, Canada
Clin Endocrinol (Oxf) 74:419-23. 2011..In the future, DAs may play an expanded role as an adjunct to physician counselling in the care of patients with thyroid cancer...
Does normalization of prolactin levels result in weight loss in patients with prolactin secreting pituitary adenomas?R Yermus
Mount Sinai Hospital, Toronto, Ontario, Canada
Clin Endocrinol (Oxf) 56:562. 2002
Gender-specific responses of lean body composition and non-gender-specific cardiac function improvement after GH replacement in GH-deficient adultsS Ezzat
Division of Endocrinology and Metabolism, University of Toronto, Toronto, Ontario, Canada M5G 2C4
J Clin Endocrinol Metab 87:2725-33. 2002..In contrast, cardiac function improvement appears to benefit both genders equally...
Granulomatous hypophysitis with psammoma bodies: a diagnostic dilemmaR Jastania
Department of Laboratory Medicine and Pathobiology, University of Toronto, University Health Network and Toronto Medical Laboratories, Canada
Endocr Pathol 15:359-63. 2004..This finding has not previously been described in the literature. The diagnostic implications of this finding are complex, and the pathogenesis of psammoma body formation in this idiopathic disorder remains unknown...
The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotrophS L Asa
Department of Pathology, Mount Sinai Hospital, Toronto, Ontario, Canada
J Clin Endocrinol Metab 81:2165-70. 1996..We conclude that SF-1 expression correlates with the expression of gonadotropins. These findings implicate SF-1 as a cell-specific transcription factor that may regulate gonadotroph differentiation in the pituitary...
Myostatin is a skeletal muscle target of growth hormone anabolic actionWei Liu
Department of Medicine, Mount Sinai Hospital and University of Toronto, Ontario, Canada
J Clin Endocrinol Metab 88:5490-6. 2003..Conversely, GH receptor antagonism resulted in up-regulation of myostatin in myoblasts. Given the potent catabolic actions of myostatin, our data suggest that myostatin represents a potential key target for GH-induced anabolism...
Dopaminergic resistant prolactinomas in the peripubertal populationCarol Huang
Department of Pediatrics, Division of Endocrinology, Hospital for Sick Children and University of Toronto, Ontario, Canada
J Pediatr Endocrinol Metab 19:951-3. 2006..Both required surgical debulking, and one has received growth hormone treatment with no increase in tumor size...
Acromegaly: re-thinking the cancer riskSiobhan Loeper
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Rev Endocr Metab Disord 9:41-58. 2008..Instead, we explore the hypothesis that acromegaly, independent of hormone secretion, is a disease that heralds genetic and/or epigenetic alterations predisposing to cancer risk elsewhere...
Medical management of pituitary adenomas: structural and ultrastructural changesSylvia L Asa
Department of Laboratory Medicine and Pathobiology, University of Toronto, University Health Network and Toronto Medical Laboratories, Ontario, Canada
Pituitary 5:133-9. 2002..In some cases, these morphologic alterations can evoke diagnostic problems...
Genetics and proteomics of pituitary tumorsSylvia L Asa
Endocrine Oncology Site Group, Mount Sinai and Princess Margaret Hospitals, University of Toronto, Toronto, Ontario, Canada
Endocrine 28:43-7. 2005..The underlying mechanisms for dysregulated cell adhesive molecules including cadherins and FGFRs are reviewed. The combined use of genetic and proteomic approaches will enhance novel drug therapeutic development...
An essential role for the hematopoietic transcription factor Ikaros in hypothalamic-pituitary-mediated somatic growthShereen Ezzat
Department of Medicine, Mount Sinai Hospital, University of Toronto, 610 University Avenue, Toronto, ON, Canada M5G 2M9
Proc Natl Acad Sci U S A 103:2214-9. 2006..These findings unmask a wider role for Ikaros in the neuroendocrine system, highlighting a critical contribution to the development of the hypothalamic-pituitary somatotrophic axis...
The pathogenesis of pituitary tumorsSylvia L Asa
Department of Laboratory Medicine and Pathobiology, University of Toronto, University Health Network and Ontario Cancer Institute, Toronto, Ontario, Canada
Annu Rev Pathol 4:97-126. 2009....
Targeting N-cadherin through fibroblast growth factor receptor-4: distinct pathogenetic and therapeutic implicationsShereen Ezzat
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Mol Endocrinol 20:2965-75. 2006..These data highlight the pathogenetic significance of N-cadherin misexpression and emphasize the importance of FGFR partnership in mediating its functions...
Mechanisms of disease: The pathogenesis of pituitary tumorsShereen Ezzat
The Freeman Centre for Endocrine Oncology, Mount Sinai Hospital, Toronto, Ontario, Canada
Nat Clin Pract Endocrinol Metab 2:220-30. 2006..Mouse models have validated the roles of these alterations, which can be targets for the development of therapies that can manage these lesions. These therapies are increasingly recognized as critical for quality of life...
Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer surveyAnna M Sawka
Division of Endocrinology, Department of Medicine, University Health Network, Toronto, Ontario, Canada
Endocr Pract 14:175-84. 2008....
A growth hormone receptor mutation impairs growth hormone autofeedback signaling in pituitary tumorsSylvia L Asa
Department of Pathology, University Health Network and Toronto Medical Laboratories, Mount Sinai Hospital, Ontario Cancer Institute, Toronto, Ontario, Canada
Cancer Res 67:7505-11. 2007....
Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wastingJohn G Esposito
Graduate Department of Rehabilitation Science, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada
Am J Physiol Endocrinol Metab 289:E494-503. 2005..62, P = 0.024). We concluded that GH treatment-induced LBM gains in HIV-associated wasting were functionally relevant, as determined by effort-independent submaximal measures of cardiopulmonary exercise testing...
The pathogenesis of pituitary tumoursSylvia L Asa
Department of Pathology and Laboratory Medicine, University of Toronto, University Health Network and Toronto Medical Laboratories, 610 University Avenue, Toronto, Ontario, Canada M5G 2M5
Nat Rev Cancer 2:836-49. 2002
Growth hormone treatment improves peripheral muscle oxygen extraction-utilization during exercise in patients with human immunodeficiency virus-associated wasting: a randomized controlled trialJohn G Esposito
Graduate Department of Rehabilitation Science, Faculty of Medicine, University of Toronto, Ontario, Canada M5G 1X5
J Clin Endocrinol Metab 89:5124-31. 2004..Therefore, treatment with rhGH leads to an improvement in peripheral muscle oxygen extraction-utilization and the Q-VO(2) relationship during exercise in patients with HIV-associated wasting despite antiretroviral therapy...
Exercise training benefits growth hormone (GH)-deficient adults in the absence or presence of GH treatmentScott G Thomas
Faculty of Physical Education and Health and Faculty of Medicine, The University of Toronto, Toronto, Ontario M5S 2W6, Canada
J Clin Endocrinol Metab 88:5734-8. 2003..The beneficial effects of exercise can mimic and are not additive to the effects of GH treatment alone...
IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling menDiana Rucker
Department of Medicine, University of Calgary, Calgary, Alberta, Canada
Clin Endocrinol (Oxf) 60:491-9. 2004..045). CONCLUSION: These data support the hypothesis that the age-related decline in bone mass in men is associated with declining levels of IGF-I and testosterone...
Ikaros isoforms in human pituitary tumors: distinct localization, histone acetylation, and activation of the 5' fibroblast growth factor receptor-4 promoterShereen Ezzat
Department of Medicine, Mount Sinai Hospital, University Health Network, University of Toronto, 610 University Avenue, 4 302, Toronto, Ontario, Canada M5G 2M9
Am J Pathol 163:1177-84. 2003..We conclude that dominant-negative Ik6 isoforms with their distinct localization and effects on Ik1 action may contribute to the altered expression of FGFR4 and possibly other target genes in human pituitary tumors...
Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cellsWei Liu
Department of Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Brain Pathol 12:412-9. 2002..Our findings highlight p27 and VD analogs as targets for manipulation and drug development respectively in the treatment of inoperable corticotroph adenomas...
Complex endocrinopathies in MEN-1: diagnostic dilemmas in endocrine oncologyNabeel Y Y Al Brahim
Department of Pathology, University Health Network, 200 Elizabeth Street, 11th Floor, Toronto, Ontario M5G 2C4, Canada
Endocr Pathol 18:37-41. 2007....
Epigenetic silencing through DNA and histone methylation of fibroblast growth factor receptor 2 in neoplastic pituitary cellsXuegong Zhu
Department of Medicine, Mount Sinai Hospital and University of Toronto, Canada
Am J Pathol 170:1618-28. 2007..These data highlight the contribution from DNA and histone methylation as epigenetic mechanisms responsible for FGFR2 silencing in pituitary neoplasia...
Pseudopheochromocytoma of pregnancyBaiju R Shah
Department of Medicine, University of Toronto, Ontario, Canada
Endocr Pract 9:376-9. 2003..CONCLUSION: This case demonstrates that severe pre-eclampsia may mimic pheochromocytoma...
Pituitary tumor AP-2alpha recognizes a cryptic promoter in intron 4 of fibroblast growth factor receptor 4ShunJiang Yu
Department of Medicine, Mount Sinai Hospital, Toronto, Ontario M5G 2M9, Canada
J Biol Chem 278:19597-602. 2003..AP-2alpha and chromatin changes may contribute to the utilization of an alternative transcription start site leading to the genesis of the tumorigenic ptd-FGFR4 isoform...
Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United StatesAnna M Sawka
Division of Endocrinology and Department of Medicine, University Health Network Toronto, Ontario, Canada
Thyroid 17:1235-42. 2007..To identify regional differences in recommendations for radioactive iodine remnant ablation (RRA) in early stage well-differentiated thyroid carcinoma (WDTC) within Canada and the United States...
Circulating and synovial levels of IGF-I, cytokines, physical function and anthropometry differ in women awaiting total knee arthroplasty when compared to menSonia M C Pagura
Centre for Studies of Physical Function, Orthopaedic and Arthritic Institute, 43 Wellesley Street East, Toronto, Ontario, Canada M4Y 1H1
J Orthop Res 23:397-405. 2005..Determine if gender differences in osteoarthritis relate to cytokine and growth factor levels...
A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivorsAnna M Sawka
Division of Endocrinology, Department of Medicine, University Health Network Toronto, Ontario, Canada
Clin Endocrinol (Oxf) 69:479-90. 2008..For women with differentiated thyroid carcinoma (DTC), the effect of radioactive iodine (RAI) therapy on gonadal and reproductive function is an important consideration...
Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasiaXuegong Zhu
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Clin Cancer Res 14:1984-96. 2008..cDNA profiling identified the cancer-testis antigen melanoma-associated antigen A3 (MAGE-A3) as a putative target negatively regulated by FGFR2...
Epigenetic control in pituitary tumorsShereen Ezzat
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
Endocr J 55:951-7. 2008..The pathogenetic and potential therapeutic implications are discussed...
Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitaryShunJiang Yu
Department of Medicine, Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada M5G 2M9
Mol Endocrinol 16:1069-78. 2002..Our findings point to a new role for Ik outside the hematopoietic system and suggest a novel transcriptional contribution with Ets and Sp1 in regulation of FGFR4 in the pituitary...
Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesisShereen Ezzat
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
J Clin Invest 109:69-78. 2002..Here we show that targeted expression of ptd-FGFR4, but not FGFR4, results in pituitary tumors that morphologically recapitulate the human disease...
Controversies in papillary microcarcinoma of the thyroidMonique Piersanti
Department of Medicine, Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada M5G 2M9
Endocr Pathol 14:183-91. 2003..Review of the literature substantiates the argument that clinically evident PTC may be distinctly different from solitary or multifocal PMC in terms of etiology and biologic behavior, supporting a conservative approach to management...
The zinc finger Ikaros transcription factor regulates pituitary growth hormone and prolactin gene expression through distinct effects on chromatin accessibilityShereen Ezzat
Department of Medicine, Mount Sinai Hospital and University of Toronto, Ontario, Canada
Mol Endocrinol 19:1004-11. 2005..These data provide evidence for Ikaros-mediated histone acetylation and chromatin remodeling in the selective regulation of pituitary GH and PRL hormone gene expression...
Comparison of body composition assessment methods in patients with human immunodeficiency virus-associated wasting receiving growth hormoneJohn G Esposito
Graduate Department of Rehabilitation Science, University of Toronto, Toronto, Ontario, Canada M5G 1V7
J Clin Endocrinol Metab 91:2952-9. 2006..Change in FM because of treatment was not accurately assessed with SKF...
Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: relation to tumor type, size, proliferation, and invasivenessZhi Rong Qian
Department of Pathology, University of Tokushima School of Medicine, Tokushima, Japan
J Clin Endocrinol Metab 89:1904-11. 2004..Moreover, detection of FGFR4 cytoplasmic staining may provide an ancillary diagnostic tool in the diagnosis of pituitary adenoma, particularly in equivocal cases...
The cost of medical care for the acromegalic patientRobert Knutzen
Pituitary Network Association, Thousand Oaks, Calif 91358, USA
Neuroendocrinology 83:139-44. 2006..We anticipate that such measures will serve to limit the psychological, emotional and economic burden of this potentially debilitating disease...
Dual inhibition of RET and FGFR4 restrains medullary thyroid cancer cell growthShereen Ezzat
Department of Medicine, Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada
Clin Cancer Res 11:1336-41. 2005..These data highlight RET and FGFR4 as therapeutic targets and suggest a potential role for the combined use of tyrosine kinase inhibitors in the management of inoperable medullary thyroid cancers...
Short-term safety and efficacy of human GH replacement therapy in 595 adults with GH deficiency: a comparison of two dosage algorithmsAnne Kehely
Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey GU20 6PH, United Kingdom
J Clin Endocrinol Metab 87:1974-9. 2002..The lower starting dose with dose titration appeared more favorable, but differences in response between genders and onset of GH deficiency need to be taken into account when setting an individual dose regimen...
Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathwaysWei Liu
Department of Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada
Am J Pathol 160:511-9. 2002..These properties support the potential utility of VD analogs in the treatment of thyroid carcinomas irrespective of their PTEN/pAkt status...
Fibroblast growth factor receptor 4 (FGFR4) mediates signaling to the prolactin but not the FGFR4 promoterShunJiang Yu
Department of Medicine, Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada
Am J Physiol Endocrinol Metab 283:E490-5. 2002..We conclude that FGFR4 mediates FGF-19 signaling to the PRL promoter. Our data also suggest a possible functional role for Ik in sorting Ets signals to the FGFR4 promoter, as distinct from the PRL promoter, where Ets partners with Pit1...
1alpha,25-Dihydroxyvitamin D3 targets PTEN-dependent fibronectin expression to restore thyroid cancer cell adhesivenessWei Liu
Department of Pathology, University Health Network and Toronto Medical Laboratories, University of Toronto, 610 University Avenue, Suite 4 302, Toronto, Ontario, Canada M5G 2M9
Mol Endocrinol 19:2349-57. 2005..Taken together, our findings highlight the significance of FN in modulating thyroid cancer cell adhesiveness and, at least in part, in mediating VD actions on neoplastic cell growth...
Inhibition of the sodium/potassium ATPase impairs N-glycan expression and functionReza Beheshti Zavareh
Ontario Cancer Institute, Princess Margaret Hospital, Canada
Cancer Res 68:6688-97. 2008..These molecules can be used as tools to better understand the role of N-glycans in normal and malignant cells. Moreover, these results may partly explain the anticancer effect of CGs in cardiovascular patients...
Growth factors and their receptors in the genesis and treatment of thyroid cancerShereen Ezzat
Department of Medicine, University of Toronto, Ontario, Canada M5G-1X5
Cancer Treat Res 122:121-9. 2004
Fibroblast growth factor receptors as molecular targets in thyroid carcinomaRosanne St Bernard
Department of Pathology, University Health Network and University of Toronto, Toronto, Ontario, Canada
Endocrinology 146:1145-53. 2005..These data indicate a role for FGFR-4 in human thyroid cancer cell progression and provide a rationale for FGFR manipulation as a potentially novel therapeutic approach...
Sp1-mediated transcriptional control of fibroblast growth factor receptor 4 in sarcomas of skeletal muscle lineageShun Jiang Yu
Department of Medicine, Mount Sinai Hospital and University of Toronto, The Freeman Centre for Endocrine Oncology and The Ontario Cancer Institute, Toronto, Ontario, Canada
Clin Cancer Res 10:6750-8. 2004..Our findings point to Sp1 as an important contributor to FGFR4 transcriptional control and elucidate a potential mechanism for the heterogeneous expression of FGFR4 in neoplasms derived from the same cell lineage...
Dexamethasone increases ubiquitin transcription through an SP-1 dependent mechanism in multiple myeloma cellsXinliang Mao
Leuk Res 32:1480-2. 2008
Distinct transcriptional control and action of fibroblast growth factor receptor 4 in differentiating skeletal muscle cellsShunJiang Yu
Department of Medicine, Mount Sinai Hospital and University of Toronto, The Freeman Centre for Endocrine Oncology and The Ontario Cancer Institute, Toronto, Ontario, Canada
Lab Invest 84:1571-80. 2004..This significantly impeded Erk1/2 phosphorylation and differentiation of myoblasts into MHC-expressing myotubes. Our findings point to distinct transcriptional regulation and action for FGFR4 in differentiating skeletal muscle cells...
Canadian guidelines for the management of adult growth hormone deficiencyEhud Ur
Division of Endocrinology, QEII Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia
Clin Invest Med 29:83-90. 2006..To develop guidelines for the management of growth hormone (GH) deficiency in Canadian adults to facilitate rational use of GH in appropriate indications...
The cancer/testis antigen melanoma-associated antigen-A3/A6 is a novel target of fibroblast growth factor receptor 2-IIIb through histone H3 modifications in thyroid cancerTetsuo Kondo
Department of Pathology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada
Clin Cancer Res 13:4713-20. 2007..In this analysis, we examined a novel target of FGFR2-IIIb signaling, melanoma-associated antigen-A3 and A6 (MAGE-A3/6)...
Diagnosis and management of hyperprolactinemiaOmar Serri
Division of Endocrinology, , , Que
CMAJ 169:575-81. 2003....
Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cellsShereen Ezzat
Department of Medicine, Mount Sinai Hospital and University of Toronto, Toronto, Ontario, Canada
Mol Endocrinol 20:2976-86. 2006..Thus, the contribution of Ik6 to tumor pathogenesis involves up-regulation of an antiapoptotic signal generated through selective acetylation of the Bcl-XL promoter...
Pituitary tumor pathogenesis--the hunt for novel candidate genes continuesShereen Ezzat
J Clin Endocrinol Metab 88:5116-8. 2003
Microadenomatosis of the pancreas in von Hippel-Lindau diseaseRunjan Chetty
Am J Surg Pathol 30:1630; author reply 1630-1. 2006
